May 15, 2020 / 9:06 PM / 20 days ago

BRIEF-Opko Health Says Entered Amendment To Commercialization License Agreement With Pfizer, Others

May 15 (Reuters) - OPKO Health Inc:

* OPKO HEALTH - ON MAY 12, ENTERED AMENDMENT TO COMMERCIALIZATION LICENSE AGREEMENT WITH PFIZER, OTHERS

* OPKO HEALTH - UNDER AMENDMENT, EFFECTIVE JAN 1, CO, PFIZER AGREED TO SHARE EQUALLY ALL COSTS FOR REMAINING DEVELOPMENT OF HGH-CTP FOR PEDIATRIC GHD

* OPKO HEALTH - UNDER AMENDMENT, AGREED TO WORK TOGETHER TO IDENTIFY ADDITIONAL PEDIATRIC INDICATION FOR DEVELOPMENT OTHER THAN PGHD ON OR BEFORE DEC. 1

* OPKO HEALTH - AGREED ON PROCESS WHEREBY PFIZER MAY SUBMIT SUPPLEMENTAL BLA FOR GHD IN ADULTS FOLLOWING RECEIPT OF REGULATORY APPROVAL OF BLA FOR PGHD Source text: (bit.ly/2WC7Ap7) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below